Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation ZNF813_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-05864 | ZNF813 | down-regulates | FGF9 | represses | R-1767 | 4 | 1 | Drugs (2) |
CMF-05867 | ZNF813 | down-regulates | NR1H4 | represses | R-2342 | 6 | 1 | Drugs (4) |
CMF-05868 | ZNF813 | down-regulates | SREBF1 | activates | R-2504 | 12 | 1 | Drugs (6) Regulator Drugs (0)Regulon Drugs (6)TEMUTERKIB, MK-8353, ULIXERTINIB, KO-947, BOTULINUM TOXIN TYPE B, RAVOXERTINIB |
CMF-05870 | ZNF813 | down-regulates | STAT4 | represses | R-1156 | 16 | 2 | Drugs (1) |
CMF-05872 | ZNF813 | up-regulates | TBP | activates | R-3475 | 18 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-05873 | ZNF813 | up-regulates | MEOX2 | activates | R-2195 | 14 | 1 | Drugs (24) Regulator Drugs (0)Regulon Drugs (24)TRELAGLIPTIN SUCCINATE, TD-139, VILDAGLIPTIN, DAVANAT, ALOGLIPTIN BENZOATE, SAXAGLIPTIN, ANAGLIPTIN, ENIBARCIMAB, TENELIGLIPTIN, CARMEGLIPTIN, BEGELOMAB, OMARIGLIPTIN, SAXAGLIPTIN HYDROCHLORIDE, GEMIGLIPTIN, BISEGLIPTIN, SITAGLIPTIN, DUTOGLIPTIN, EVOGLIPTIN, ALOGLIPTIN, BELAPECTIN, LINAGLIPTIN, TRELAGLIPTIN, GOSOGLIPTIN, SITAGLIPTIN PHOSPHATE |
CMF-05875 | ZNF813 | down-regulates | DLX5 | represses | R-3309 | 6 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-05882 | ZNF813 | up-regulates | TRAF4 | represses | R-2271 | 14 | 4 | Drugs (2) |